Intranasal IgM vaccine for Covid-19

The results of a study in Nature demonstrate that intranasal administration of an engineered IgM neutralizing antibody can improve efficacy, reduce resistance, and simplify the prophylactic and therapeutic treatment of COVID-19.

https://www.nature.com/articles/s41586-021-03673-2